No Data
No Data
On April 24, the repurchase collection | AIA, CHINAHONGQIAO, and others have repurchased shares, with AIA spending 0.279 billion Hong Kong dollars.
According to the documents disclosed by HKEX on April 25, companies like $AIA(01299.HK)$ and $CHINAHONGQIAO(01378.HK)$ have repurchased shares. ① $AIA(01299.HK)$ repurchased 5 million ordinary shares on April 24, totaling 0.279 billion HKD, with a repurchase price ranging from 56.7 HKD to 55.25 HKD per share. Since the repurchase authorization resolution, the cumulative number of repurchased shares is 0.57 billion shares, accounting for 5.069% of the total shares issued at the time the ordinary resolution was passed. ② $CHINAHONGQIAO(01378.HK)$ on April 2
April 23 buyback collection | AIA, HSBC Holdings and others have conducted buybacks, among which AIA spent 0.138 billion Hong Kong dollars.
According to the documents disclosed by HKEX on April 24, AIA (01299.HK), HSBC Holdings (00005.HK), and others repurchased shares. ① AIA (01299.HK) repurchased 2.481 million ordinary shares on April 23, involving an amount of 0.138 billion Hong Kong dollars, with a repurchase price between 55.9 HKD and 55 HKD per share. Since the repurchase authorization resolution, the cumulative number of securities repurchased is 0.565 billion shares, accounting for 5.025% of the number of shares issued at the time the ordinary resolution was approved. ② HSBC Holdings (00005.HK) on April 2
The industry is hotly discussing the future trends of nuclear medicine, will Hybrid NewCo become a new model for the RDC Industry to venture abroad? | Industry Observation
① Today, the 2025 Future XDC New Drug Conference is held in Chengdu; ② Executives from companies such as Baillie Tianheng and Kelun Botai, along with numerous experts and scholars in the industry, will jointly discuss cutting-edge technologies in ADC/nuclear drug development, overseas strategies, and other Topics.
April 16th buyback collection | AIA, HSBC Holdings, and others have made buybacks, with AIA spending 0.189 billion HKD.
According to the documents disclosed by HKEX on April 17, shares were repurchased by $AIA(01299.HK)$, $HSBC Holdings(00005.HK)$, and others. ① $AIA(01299.HK)$ repurchased 3.6 million ordinary shares on April 16, involving an amount of 0.189 billion Hong Kong dollars, with a repurchase price ranging from 52.85 Hong Kong dollars to 51.85 Hong Kong dollars per share. Since the resolution for the repurchase authorization, the cumulative number of repurchased securities has reached 0.553 billion shares, accounting for 4.922% of the number of shares issued at the time of the ordinary resolution approval. ② $HSBC Holdings(00005.HK)$ on April...
Repurchase collection on April 15 | AIA, CHINAHONGQIAO, and others have repurchased, with AIA spending 0.252 billion HKD.
According to documents disclosed by HKEX on April 16, AIA (01299.HK), CHINAHONGQIAO (01378.HK), and others have repurchased shares. ① AIA (01299.HK) repurchased 4.8 million ordinary shares on April 15, involving an amount of 0.252 billion HKD, with a repurchase price ranging from 52.8 HKD to 52 HKD per share. Since the repurchase authorization resolution, the cumulative number of securities repurchased is 0.549 billion shares, accounting for 4.89% of the number of shares issued when the ordinary resolution was passed. ② CHINAHONGQIAO (01378.HK) repurchased on April 15.
Morgan Stanley: Raises the Target Price for WEIGAO GROUP (01066) to HKD 5.90 and maintains a "Shareholding" rating.
Morgan Stanley predicts that overall sales will grow by 9% and 7% in 2025 and 2026 respectively, with profit growth slowing down, as Morgan Stanley remains cautiously optimistic about the contribution of new products and regulatory impacts.